Monday, 20 May 2019

Drug Discovery News

  • Protagonist, Ironwood expand peptide R&D deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

    Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging Protagonist's proprietary disulfide‐rich pep...Read more

  • UK recommends BMS's Yervoy for skin cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

    Singapore: National Institute of Health and Clinical Excellence (NICE) has decided to recommend Bristol-Myers Squibb's YERVOY (ipilimumab), which is approved in the European Union for the t...Read more

  • Singapore opens research centre for circulating tumour cell

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital (SGH) have together established Circ...Read more

  • TauRx gets $10.5 mn funding from Dundee Corp

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corporation. The investment will be used by TauRx primarily to support the...Read more

  • FDA: AbbVie Hepatitis therapy is a 'breakthrough'

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatment of genotype (GT1) hepatitis C virus (HCV) infection has been desig...Read more

  • NIH to develop therapeutics for nicotine addiction

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: The National Institutes of Health (NIH), US, has launched three projects that will focus on development of therapeutics for fragile X syndrome, nicotine addiction, and age-relat...Read more

  • NZ firm to raise funds for Australia trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 to finance a multi-center phase IIB trial of MIS416 in patients with s...Read more

  • TSRI, Takeda expand research collaboration

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search for new drug targets for a variety of diseases. The...Read more

  • Prima recruits patients for cancer vaccine trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized several centers in Ukraine to start enrolling pat...Read more

  • Merck pays Bionomics $172mn for pain molecules

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and Canada, to discover and develop novel small molecule candidates for ...Read more

  • Bayer initiates trial of new rFVIII to treat hemophilia A

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that is designed to evaluate its investigational compound BAY94-9027 for th...Read more

  • Eli Lilly, China firm to co-develop diabetes drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    ‎Singapore: China based pharmaceutical company, Yabao Pharmaceutical, has partnered with Eli Lilly to co-develop Lilly's glucokinase activator (GKA), LY2608204, that has completed Pha...Read more

  • ScinoPharm, Coland develop cancer generics in China

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    ‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to develop a series of generic oncological drugs for China. Several Acti...Read more

  • VM202 trial completes patient administration

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients for the company's ongoing phase II clinical trial of VM202-DPN in US/K...Read more

  • Researchers find gene mutation to lower heart disease

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: By scouring the DNA of thousands of patients, researchers at Broad Institute, Massachusetts General Hospital, have discovered four rare gene mutations that lower the levels of tr...Read more

  • EMA to review marketing plea for antipsychotic medication

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an atypical antipsychotic medication lurasidone hydrochloride. The product ...Read more

  • Chipscreen gets SFDA nod after accelerated review

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2013

    ‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, registrational phase II Chipel trial of Chidamide (Epidaza), an orally...Read more

  • FDA affirms superiority of Pradaxa over warfarin

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

    Singapore: US Food and Drug Administration has affirmed Boehringer Ingelheim's Pradaxa 150mg superior in reducing ischemic and hemorrhagic strokes relative to warfarin. This positive change...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls